|
Dronabinol Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: (-)-.DELTA.9-Tetrahydrocannabinol, Abbott 40566, Delta(9)-Tetrahydrocannibinol, Delta-9-THC, Delta-9-Tetrahydrocannabinol, Delta9-THC, Marinol, SP 104, SP-104, SYNDROS, THC, Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol, Tetrahydrocannabinol
Duarte, California1 trial
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
Phase 2
Chicago, Illinois1 trial
Dronabinol After Arthroscopic Surgery
Northwestern University Feinberg School of Medicine
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.